Skip to content
Open access

Transcriptomics Reveals Mesenchymal Stem Cell-Derived Exosomes Activate Hepatocyte Longevity-Regulating Pathway in Acute-On-Chronic Liver Failure

Oct 2026 · Genes · 0 citations

TL;DR

Integrative transcriptomic analysis revealed that MSC-exos activate the FoxO/Cat axis through miRNA-mRNA interactome remodeling, thereby orchestrating coordinated antioxidant, pro-autophagic, and anti-senescence effects alongside immune microenvironment reprogramming in liver failure.

Abstract

Background: Acute-on-chronic liver failure (ACLF), a rapidly progressive condition with high short-term mortality in patients with chronic liver disease, has shown therapeutic responsiveness to mesenchymal stem cell-derived exosomes (MSC-exos) in preclinical studies, where exosome administration significantly attenuates hepatic injury. To comprehensively delineate the mechanistic basis of this therapeutic effect, we conducted integrated miRNA and mRNA sequencing analyses on liver tissues obtained from exosome-treated ACLF murine models. Methods: Mice subjected to a CCl4-based acute-on-chronic liver injury regimen received saline or an MSC-derived extracellular vesicle (EV) preparation intravenously through the tail vein. Liver miRNA and mRNA profiles were examined by differential expression, GSEA, functional enrichment, exploratory LASSO feature selection and integrative network analysis. Expression measurements were complemented by senescence-associated transcript assays, a Cat 3′UTR reporter assay and CCK-8 assessment in cell models. Results: Exosome treatment significantly activated longevity-regulating pathways, mitophagy, and glutathione metabolism in ACLF mice, concurrent with characteristic remodeling of hepatic immune infiltration involving follicular helper T cells, activated NK cells, and macrophage subpopulations. Hepatic injury severity demonstrated positive correlations with mmu-let-7j and Mmp27, and negative associations with mmu-let-7f-2-3p and Tmem8b. The reconstructed miRNA-mRNA network converged on FoxO signaling-mediated regulation of oxidative stress, cellular senescence and autophagy, with FoxO/Catalase (Cat) identified as core regulators. Experimental studies confirmed that MSC-derived exosomes downregulated miR-7b-5p in hepatocytes and enhanced Cat expression, with attenuation of cellular senescence. Conclusions: Integrative transcriptomic analysis revealed that MSC-exos activate the FoxO/Cat axis through miRNA-mRNA interactome remodeling, thereby orchestrating coordinated antioxidant, pro-autophagic, and anti-senescence effects alongside immune microenvironment reprogramming in liver failure. These findings establish a pivotal theoretical framework for developing exosome-based therapeutic strategies targeting hepatic disorders.

Read PDF

Similar papers

Review Open access Oct 2026

Mechanistic insights and translational perspectives on liver fibrosis through single-cell transcriptomics

Liver fibrosis is a defining feature of chronic liver diseases and can progress to cirrhosis and liver failure. Single-cell RNA sequencing (scRNA-seq) enables high-resolution analysis of cellular heterogeneity and multicellular interactions during fibrogenesis. In this narrative review, we analyzed published single-cel...

Wei-Wei Lu, Jun Xu, Ke-Xin Wang et al. · 0 citations
Open access Oct 2026

Human embryonic stem cell–derived mesenchymal stem cells ameliorate mitochondrial oxidative dysfunction in metabolic dysfunction–associated steatotic liver disease

Abstract Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common chronic liver disease with significant clinical burden. This study investigated the therapeutic potential of embryonic stem cell-derived mesenchymal stem cells (ESC-MSCs) in cellular and murine models of MASLD. Methods He...

Min Kyung Park, Yun-Bin Lee, Se-Mi Jung et al. · 0 citations
Open access Oct 2026

Apoptotic mesenchymal stem cells drive myocardial repair by activating RUNX1-TK1-mediated pyrimidine metabolic reprogramming in macrophages

Mesenchymal stem cell (MSC) therapy is promising for acute myocardial infarction (AMI), yet low post-transplantation survival remains a major hurdle. Emerging evidence suggests that apoptotic MSCs (aMSCs) are not mere "treatment failures" but actively modulate immune responses. Based on our preliminary findings t...

T. Xiao, Wen-Bin Lu · 0 citations
Open access Sep 2026

Bone marrow mesenchymal stem cell-derived exosomal miR-618-3p is associated with reduced proliferation and epithelial-mesenchymal transition markers in a chronic atrophic gastritis cell model: A preliminary in-vitro study.

BACKGROUND Exosomes derived from bone marrow mesenchymal stem cells (BMSCs) can deliver microRNAs to recipient cells and modulate their functions; however, investigations into their molecular effects have frequently relied on surrogate cancer cell lines, whose relevance to benign CAG pathology remains uncertain and mus...

Jin-Jian Liu, X. Zhang, Yue Li · 0 citations
Open access Oct 2026

A cell-free therapeutic strategy using MSC-derived exosomes and activated platelet lysate for acute kidney injury induced by rhabdomyolysis

Rhabdomyolysis-induced acute kidney injury (AKI) is primarily driven by myoglobin-mediated tubular toxicity, leading to pronounced oxidative stress, inflammation, and apoptosis. Given the limited availability of effective targeted therapies, this study aimed to evaluate the efficacy of a combined cell-free approach usi...

Neveen A. Salem, Shaimaa A. ElShebiney, E. Salem et al. · 0 citations
Open access Oct 2026

Extracellular Vesicles from Human Induced Pluripotent Stem Cells Reduce Lung Ischemia-Reperfusion Injury via Cytoprotective Mechanisms in both 2D Cultures and a Human Airway Organoid Model

It is demonstrated that hiPSC-EV exert broad cytoprotective effects in pulmonary IRI through coordinated regulation of inflammation, oxidative stress, and cell death through coordinated regulation of inflammation, oxidative stress, and cell death.

R. Tinnirello, Maria Chiara Iachini, M. Cimino et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.